Biolase Expects to Post Record Sales

Biolase Technology Inc., a San Clemente company that has developed lasers for surgical and dental work, expects to report record sales and increased earnings for the second quarter.

The company, which said last month that it was increasing its sales force, also expects sales for the year to grow by 50%. For last year, Biolase reported $17.9 million in sales and a loss of $408,000, or 2 cents a share.

Analysts on average have forecast earnings of 2 cents for the quarter and annual sales of up to $27.5 million.

Biolase stock gained 92 cents to $4.92 on Nasdaq.